Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the ...

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO, whilst ...

After losing its measles elimination status earlier this year, the UK has launched a campaign urging around a million ...

Let me start with something most strategy decks dance around: the patent cliff isn't the problem. It's the symptom. Every ...

Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...

Women with endometriosis in England could soon be offered simple non-invasive tests for diagnosis of their condition, rather ...

Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...

As practising oncologists, we've seen firsthand how a cancer diagnosis changes the way patients engage with information.

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These tiny tumour samples can unlock a wealth of molecular information, information ...

This month, the European Commission granted centralised marketing authorisation for Zandoriah (teriparatide), a biosimilar to ...

Roche's Genentech unit has forged an alliance with Astex, worth up to $515 million, to partner on a fragment-based drug ...

The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for ...